I am curious about the ongoing expenses vs revenue. I cannot help but think we will be floored by the legal and accounting costs being incurred between acquisitions and auditing. Of course, a lot of that may not show up until the next Q report. No doubt the check boxes for the NAZ app are key!
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links